Cue Biopharma Inc (CUE)
1.895
+0.16
(+8.91%)
USD |
NASDAQ |
May 20, 12:22
Cue Biopharma Cash from Operations (TTM): -38.91M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -38.91M |
| December 31, 2023 | -39.96M |
| September 30, 2023 | -39.52M |
| June 30, 2023 | -38.59M |
| March 31, 2023 | -41.07M |
| December 31, 2022 | -41.81M |
| September 30, 2022 | -41.94M |
| June 30, 2022 | -41.69M |
| March 31, 2022 | -38.62M |
| December 31, 2021 | -38.84M |
| September 30, 2021 | -35.19M |
| June 30, 2021 | -36.25M |
| March 31, 2021 | -33.34M |
| Date | Value |
|---|---|
| December 31, 2020 | -32.49M |
| September 30, 2020 | -31.93M |
| June 30, 2020 | -33.45M |
| March 31, 2020 | -33.27M |
| December 31, 2019 | -30.80M |
| September 30, 2019 | -28.26M |
| June 30, 2019 | -25.35M |
| March 31, 2019 | -25.13M |
| December 31, 2018 | -26.41M |
| September 30, 2018 | -24.36M |
| June 30, 2018 | -21.74M |
| March 31, 2018 | -18.44M |
| December 31, 2017 | -12.14M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-41.94M
Minimum
Sep 2022
-25.35M
Maximum
Jun 2019
-36.06M
Average
-37.42M
Median
Cash from Operations (TTM) Benchmarks
| Precision BioSciences Inc | -71.63M |
| NovaBay Pharmaceuticals Inc | -4.516M |
| Palatin Technologies Inc | -33.74M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -18.27M |